These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28153453)

  • 21. Interactions between bile salts, gut microbiota, and hepatic innate immunity.
    Schubert K; Olde Damink SWM; von Bergen M; Schaap FG
    Immunol Rev; 2017 Sep; 279(1):23-35. PubMed ID: 28856736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGR5 signaling mitigates parenteral nutrition-associated liver disease.
    Willis KA; Gomes CK; Rao P; Micic D; Moran ER; Stephenson E; Puchowicz M; Al Abdallah Q; Mims TS; Gosain A; Yin D; Talati AJ; Chang EB; Han JC; Pierre JF
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G322-G335. PubMed ID: 31905022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.
    Fiorucci S; Distrutti E
    Trends Mol Med; 2015 Nov; 21(11):702-714. PubMed ID: 26481828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile Acid Physiology.
    Di Ciaula A; Garruti G; Lunardi Baccetto R; Molina-Molina E; Bonfrate L; Wang DQ; Portincasa P
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s4-s14. PubMed ID: 29080336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile acid signaling in renal water regulation.
    Li S; Li C; Wang W
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F73-F76. PubMed ID: 31091123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine and paracrine role of bile acids.
    Keitel V; Kubitz R; Häussinger D
    World J Gastroenterol; 2008 Oct; 14(37):5620-9. PubMed ID: 18837077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bile acid receptors and the kidney.
    Herman-Edelstein M; Weinstein T; Levi M
    Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):56-62. PubMed ID: 29045336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bile acids in regulation of intestinal physiology.
    Keating N; Keely SJ
    Curr Gastroenterol Rep; 2009 Oct; 11(5):375-82. PubMed ID: 19765365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.
    Copple BL; Li T
    Pharmacol Res; 2016 Feb; 104():9-21. PubMed ID: 26706784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
    Prawitt J; Caron S; Staels B
    Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gut microbiome-bile acid axis in hepatocarcinogenesis.
    Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
    Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
    Chávez-Talavera O; Tailleux A; Lefebvre P; Staels B
    Gastroenterology; 2017 May; 152(7):1679-1694.e3. PubMed ID: 28214524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular determinants of gastrointestinal and liver cancers: role of bile acid activated nuclear receptors.
    Renga B; Mencarelli A; Cipriani S; Distrutti E
    Curr Top Med Chem; 2012; 12(6):625-36. PubMed ID: 22242858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acids: from digestion to cancers.
    Baptissart M; Vega A; Maqdasy S; Caira F; Baron S; Lobaccaro JM; Volle DH
    Biochimie; 2013 Mar; 95(3):504-17. PubMed ID: 22766017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling?
    Baptissart M; Vega A; Martinot E; Baron S; Lobaccaro JM; Volle DH
    Cell Mol Life Sci; 2013 Dec; 70(23):4511-26. PubMed ID: 23784309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases.
    Stanimirov B; Stankov K; Mikov M
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):18-33. PubMed ID: 25655287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.